Active Not RecruitingNCT06225232
Psilocybin in the Treatment of Addiction: A-Proof-of-Concept Study
Medication studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 21, 2025
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 16
- Sponsor
- McMaster University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06225232
- Official title
Show the full official title
An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hamilton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is McMaster University, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin combined with Psychotherapy.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
